CORVUS PHARMACEUTICALS INC's ticker is CRVS and the CUSIP is 221015100. A total of 51 filers reported holding CORVUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 3.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $332 | -99.9% | 390,000 | -25.3% | 0.52% | -4.0% |
| Q3 2022 | $427,000 | -6.4% | 522,009 | +13.5% | 0.55% | +1.3% |
| Q2 2022 | $456,000 | -3.4% | 460,103 | +60.0% | 0.54% | -27.5% |
| Q1 2022 | $472,000 | +1.5% | 287,500 | +49.0% | 0.74% | +24.4% |
| Q4 2021 | $465,000 | -51.0% | 192,909 | -1.7% | 0.60% | -53.2% |
| Q3 2021 | $949,000 | +34.6% | 196,168 | -25.7% | 1.28% | +32.0% |
| Q2 2021 | $705,000 | -8.1% | 263,975 | +6.0% | 0.97% | +11.8% |
| Q1 2021 | $767,000 | +14.0% | 249,006 | +31.7% | 0.87% | -23.7% |
| Q4 2020 | $673,000 | +77.6% | 189,081 | +86.8% | 1.14% | +288.1% |
| Q2 2019 | $379,000 | -37.3% | 101,218 | -32.6% | 0.29% | -4.6% |
| Q1 2019 | $604,000 | +21.8% | 150,199 | +11.2% | 0.31% | -2.8% |
| Q4 2018 | $496,000 | +15.3% | 135,123 | +400.5% | 0.32% | +105.2% |
| Q3 2017 | $430,000 | – | 27,000 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ADAMS STREET PARTNERS LLC | 3,275,616 | $28,105,000 | 4.42% |
| Novo Holdings A/S | 4,420,516 | $37,928,000 | 3.01% |
| BVF INC/IL | 1,890,507 | $16,221,000 | 1.42% |
| Orbimed Advisors | 5,967,584 | $51,202,000 | 0.62% |
| COWEN INC. | 588,706 | $5,051,000 | 0.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,000 | $710,000 | 0.34% |
| SPHERA FUNDS MANAGEMENT LTD. | 321,430 | $2,758,000 | 0.32% |
| EcoR1 Capital, LLC | 351,401 | $3,015,000 | 0.27% |
| Rock Springs Capital Management LP | 575,000 | $4,934,000 | 0.18% |
| Hikari Power Ltd | 32,090 | $275,000 | 0.03% |